Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

(marketscreener.com) ACTON, Mass., Aug. 16, 2022 -- Bluejay Diagnostics, Inc. , a medical diagnostics company focused on developing cost-effective, rapid, near-patient tests for triage and monitoring of disease progression, today announced that it will hold a virtual Key Opinion Leader event on IL-6 Testing in Critical Care Settings: The Emerging Use of...https://www.marketscreener.com/quote/stock/BLUEJAY-DIAGNOSTICS-INC-129164812/news/Bluejay-Diagnostics-Inc-to-Host-Key-Opinion-Leader-Event-on-IL-6-Testing-in-Critical-Care-Settings-41329800/?utm_medium=RSS&utm_content=20220816